RALEIGH, N.C. — March 10, 2026: Opus Genetics, Inc. (NASDAQ: IRD) reported mixed fourth-quarter results this morning that revealed a widening loss...
The UK government has announced a innovative £50 million investment in mental health research, marking a significant step toward revolutionizing treatment options...